Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 26, 2023	Mar. 27, 2022
Operating activities
Net income before attribution to noncontrolling interests	$ 22,546	$ 11,427
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for allowance for credit losses on accounts and notes receivable	513	15,167
Depreciation and amortization	14,721	11,940
Refranchising and impairment loss	0	11,160
Deferred income taxes	2,031	(1,817)
Stock-based compensation expense	3,898	4,176
Other	496	(2,135)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	2,182	(2,503)
Income tax receivable	2,822	(1,151)
Inventories	4,330	(4,731)
Prepaid expenses and other current assets	(4,351)	77
Other assets and liabilities	71	(654)
Accounts payable	(310)	7,359
Income and other taxes payable	(512)	8,013
Accrued expenses and other current liabilities	(5,413)	(29,469)
Deferred revenue	(2,236)	(1,465)
Net cash provided by operating activities	40,788	25,394
Investing activities
Purchases of property and equipment	(18,410)	(10,233)
Notes issued	(976)	(272)
Repayments of notes issued	1,069	3,432
Acquisitions, net of cash acquired	0	(1,250)
Other	42	8
Net cash used in investing activities	(18,275)	(8,315)
Financing activities
Net proceeds of revolving credit facilities	208,200	47,000
Proceeds from exercise of stock options	614	741
Acquisition of Company common stock	(209,640)	(32,709)
Dividends paid to common stockholders	(14,603)	(12,608)
Tax payments for equity award issuances	(5,999)	(7,461)
Distributions to noncontrolling interests	(23)	(685)
Other	(1,761)	(1,065)
Net cash used in financing activities	(23,212)	(6,787)
Effect of exchange rate changes on cash and cash equivalents	34	(233)
Change in cash and cash equivalents	(665)	10,059
Cash and cash equivalents at beginning of period	47,373	70,610
Cash and cash equivalents at end of period	$ 46,708	$ 80,669